Literature DB >> 31828594

Ixazomib-induced Sweet's syndrome.

Takuya Suyama1, Syusaku Ito2, Atsushi Shinagawa3.   

Abstract

Entities:  

Keywords:  Ixazomib; Multiple myeloma; Sweet’s syndrome

Year:  2019        PMID： 31828594     DOI： 10.1007/s12185-019-02797-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  3 in total

Review 1.  New Practical Aspects of Sweet Syndrome.

Authors:  Tejas P Joshi; Sarah K Friske; David A Hsiou; Madeleine Duvic
Journal:  Am J Clin Dermatol       Date:  2022-02-14       Impact factor: 7.403

2.  Cystargolide-based amide and ester Pz analogues as proteasome inhibitors and anti-cancer agents.

Authors:  Carlos R Viera; Bradley T Stevens; Talysa Viera; Cameron Zielinski; Lee A Uranga; Snezna Rogelj; Praveen L Patidar; Rodolfo Tello-Aburto
Journal:  R Soc Open Sci       Date:  2022-09-28       Impact factor: 3.653

3.  Sweet Syndrome Associated with Ixazomib

Authors:  İrfan Yavaşoğlu; Zahit Bolaman
Journal:  Turk J Haematol       Date:  2021-06-11       Impact factor: 1.831
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.